Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
35.86
+0.81 (2.31%)
At close: Apr 14, 2026, 4:00 PM EDT
35.86
0.00 (0.00%)
After-hours: Apr 14, 2026, 5:37 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $2.12 billion as of April 14, 2026. Its market cap has increased by 426.50% in one year.
Market Cap
2.12B
Enterprise Value
1.72B
1-Year Change
426.50%
Ranking
Category
Stock Price
$35.86
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $2.12B, an increase of 163.67%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 2.07B | 14.36% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 2.16B |
| Definium Therapeutics | 2.15B |
| Aurinia Pharmaceuticals | 2.10B |
| AnaptysBio | 2.02B |
| Adaptive Biotechnologies | 1.97B |
| Mesoblast | 1.94B |
| Zymeworks | 1.94B |
| Agios Pharmaceuticals | 1.93B |